Activation fees

No definition available.

Name:	psnl_ActivationFees
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Agreement reserve.

+ References

No definition available.

+ Details

Name:	psnl_AgreementReserve
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Class of warrant or right, expense recognized.

+ References

No definition available.

+ Details

Name:	psnl_ClassOfWarrantOrRightExpenseRecognized
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Class of warrant or right intrinsic value per share.

+ References

No definition available.

+ Details

Name:	psnl_ClassOfWarrantOrRightIntrinsicValuePerShare
Namespace Prefix:	psnl_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Fair market value of promotional and commercialization services

+ References

No definition available.

+ Details

Name:	psnl_FairMarketValueOfPromotionalAndCommercializationServices
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

First milestone fee.

+ References

No definition available.

+ Details

Name:	psnl_FirstMilestoneFee
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

First milestone payments upon achievement of specified clinical validations

+ References

No definition available.

+ Details

Name:	psnl_FirstMilestonePaymentsUponAchievementOfSpecifiedClinicalValidations
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Increase (decrease) in fair value of warrants.

+ References

No definition available.

+ Details

Name:	psnl_IncreaseDecreaseInFairValueOfWarrants
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Initial fair value of warrants.

+ References

No definition available.

+ Details

Name:	psnl_InitialFairValueOfWarrants
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Market development fees payable.

+ References

No definition available.

+ Details

Name:	psnl_MarketDevelopmentFeesPayable
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Market development fees received.

+ References

No definition available.

+ Details

Name:	psnl_MarketDevelopmentFeesReceived
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of Warrents

+ References

No definition available.

+ Details

Name:	psnl_NumberOfWarrents
Namespace Prefix:	psnl_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of common stock owned.

+ References

No definition available.

+ Details

Name:	psnl_PercentageOfCommonStockOwned
Namespace Prefix:	psnl_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of its gross revenues attributable to such license

+ References

No definition available.

+ Details

Name:	psnl_PercentageOfItsGrossRevenuesAttributableToSuchLicense
Namespace Prefix:	psnl_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Second Milestone Fees Payable Subject to Achieving Two Additial Clinical Validations

+ References

No definition available.

+ Details

Name:	psnl_SecondMilestoneFeesPayableSubjectToAchievingTwoAdditialClinicalValidations
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Stock issuance costs.

+ References

No definition available.

+ Details

Name:	psnl_StockIssuanceCosts
Namespace Prefix:	psnl_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of expense (income) related to adjustment to fair value of warrant liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 25
-Paragraph 13
-SubTopic 10
-Topic 480
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481766/480-10-25-13

+ Details

Name:	us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Cash received for fees during the current period. This element excludes cash proceeds from license fees.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_ProceedsFromFeesReceived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 14
-Subparagraph (a)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-14

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).

+ References

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

+ Details

Name:	us-gaap_ReceivablesNetCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of transactions with related party during the financial reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-3

+ Details

Name:	us-gaap_RelatedPartyTransactionAmountsOfTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-SubTopic 10
-Topic 505
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.

+ References

+ Details

Name:	us-gaap_WarrantsAndRightsOutstandingMaturityDate
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=psnl_TempusWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=psnl_TempusAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=psnl_TempusMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=psnl_FirstWarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=psnl_InvestmentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=psnl_MerckSharpAndDohmeLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=psnl_InvestmentAgreementWithMerckMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Related Party Transactions - Additional Information (Details) $ / shares in Units, $ in Thousands					1 Months Ended	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 19, 2024 USD ($) $ / shares shares	Aug. 31, 2024 USD ($) $ / shares shares	Nov. 28, 2023 USD ($) Warrants $ / shares shares	Nov. 30, 2023 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Related Party Transaction [Line Items]
Proceeds from issuance of Tempus Warrants							$ 6,000
Change in fair value of convertible preferred stock warrant liability						$ 18,274	4,027
Proceeds from sale of stock						30,079	3,513
Tempus Warrants
Related Party Transaction [Line Items]
Warrants and rights outstanding			$ 28,300
Class of warrant or right intrinsic value per share \| $ / shares			$ 3.07
Tempus Agreement
Related Party Transaction [Line Items]
Market development fees				$ 6,000		6,000
Activation fees						3,000
Number of warrants \| Warrants				2
Initial fair value				$ 6,900
Proceeds from issuance of Tempus Warrants				6,000
Change in fair value of convertible preferred stock warrant liability							900
Increase in fair value of warrants								$ 3,100
First milestone fee						3,000
Activation Fees						3,000
Market development fees	$ 6,000					6,000
Market development fees received						3,000
Tempus Agreement \| Other Income (Expense)
Related Party Transaction [Line Items]
Change in fair value of convertible preferred stock warrant liability				$ 900
Warrant expense recognized						18,300	$ 4,000
Tempus Agreement \| Tempus Warrants
Related Party Transaction [Line Items]
Proceeds from issuance of Tempus Warrants						$ 6,000
Minimum \| Tempus Agreement
Related Party Transaction [Line Items]
Percentage of its gross revenues attributable to such license						10.00%
Maximum \| Tempus Agreement
Related Party Transaction [Line Items]
Percentage of its gross revenues attributable to such license						20.00%
Tempus \| Tempus Agreement
Related Party Transaction [Line Items]
Activation fees					$ 3,000
First milestone fees payment upon achivement of specified clinical validations					3,000
Second milestone fees payment subject to achieving two additional clinicial validations					6,000
Fair market value of promotional and commercialization services					9,600
Warrant issued to purchase stock \| shares			9,218,800
Warrant exercise price per share \| $ / shares			$ 2
Warrants and rights outstanding			$ 18,400
Activation Fees					3,000
Tempus \| Tempus Agreement \| First Warrant
Related Party Transaction [Line Items]
Warrant exercise price per share \| $ / shares				$ 1.5
Warrant expiration date				Dec. 31, 2024
Tempus \| Tempus Agreement \| Tempus Warrants
Related Party Transaction [Line Items]
Warrant exercise price per share \| $ / shares				$ 2.5
Warrant expiration date				Dec. 31, 2025
Tempus \| Investment Agreement
Related Party Transaction [Line Items]
Number of shares issued \| shares			3,500,000
Share Price \| $ / shares			$ 5.07
Proceeds from sale of stock			$ 17,700
Stock issuance cost			$ 1,100
Tempus \| Minimum
Related Party Transaction [Line Items]
Percentage of common stock owned	10.00%					10.00%
Tempus \| Maximum \| Tempus Agreement
Related Party Transaction [Line Items]
Market development fees					$ 12,000
Tempus \| Maximum \| Tempus Agreement \| First Warrant
Related Party Transaction [Line Items]
Warrant issued to purchase stock \| shares				4,609,400
Tempus \| Maximum \| Tempus Agreement \| Tempus Warrants
Related Party Transaction [Line Items]
Warrant issued to purchase stock \| shares				4,609,400
Merck Sharp & Dohme LLC \| Investment Agreement with Merck
Related Party Transaction [Line Items]
Number of shares issued \| shares		14,044,943
Share Price \| $ / shares		$ 3.56
Proceeds from sale of stock		$ 50,000
Stock issuance cost		300
Agreement reserve		$ 10,000
Invoice amount	$ 2,000
Receivable	$ 2,500					$ 2,500